[Clinical experience with BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
BRL 25000 granules containing amoxicillin 2 parts and clavulanic acid 1 part, were administered to 14 patients with pediatric infections. The overall efficacy rate was 71.4% (10/14). An adverse reaction was observed in 1 case with diarrhea, but there were no other side effects or abnormal laboratory findings noted.
D000284:Administration, Oral; D000293:Adolescent; D000367:Age Factors; D000658:Amoxicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019980:Amoxicillin-Potassium Clavulanate Combination; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004304:Dosage Forms; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D004304:Dosage Forms; D004338:Drug Combinations; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin